You are here
- Home
- Therapy Areas
- Oncology/Infection
Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase
- Disease
- non-small cell lung cancer
- Drug Name
- non drug study (oncology)
- Generic Name
- No drug
- Sponsor
- AstraZeneca
- Drug Status
- Non-Drug
- Phase
- Non-Interventional Study
- Start Date
- Jan 19, 1971
- Study Name
- NIS-OFR-DUM-2010/1
- Study Id
- NIS-OFR-DUM-2010/1
- ClinicalTrials.gov ID
- NCT01167972
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
